F1000 Research
See the following -
A Case for Open Peer Review for Clinical Trials
A few weeks ago I played the part of an expert witness in the Medical Journalist Association’s mock trial, Trials on Trial. The charge was: “Is the current system of publishing clinical trials fit for purpose?” The jury’s verdict was a resounding ‘no’. You can read more about the event in Jane Feinmann’s write up on the BMJ Group Blogs.
- Login to post comments
Open Access 2015: A Year Access Negotiators Edged Closer to the Tipping Point
It’s the year many negotiators got seriously tough on double dipping – charging for both the ability to read (via subscriptions) and for publishing (author processing charges, or APCs). Last year it was France getting tough on the toughest negotiator: Elsevier. This year, the Netherlands took it right to the brink of cutting Elsevier loose. It was summed up by a January headline: “Dutch universities dig in for long fight over open access.” Coming into the new year, other nations were taking up positions about the future they want to see too...Here’s a month-by-month roundup of some of the major action...
- Login to post comments
Open Publishing Can Improve Access To Knowledge
There have been increasing demands for more transparency in the reporting of research findings, which has built up pressure on all those involved in making and testing potential new drugs, biologics and medical devices.
- Login to post comments